GPP
FPRX
Great Point Partners’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-547,712
| Closed | -$3.3M | – | 38 |
|
2019
Q2 | $3.3M | Sell |
547,712
-1,850,697
| -77% | -$11.2M | 0.37% | 23 |
|
2019
Q1 | $32.1M | Hold |
2,398,409
| – | – | 3.18% | 14 |
|
2018
Q4 | $22.3M | Buy |
2,398,409
+750,656
| +46% | +$6.98M | 2.82% | 14 |
|
2018
Q3 | $22.9M | Buy |
1,647,753
+387,753
| +31% | +$5.4M | 3.57% | 15 |
|
2018
Q2 | $19.9M | Buy |
1,260,000
+391,900
| +45% | +$6.2M | 2.76% | 14 |
|
2018
Q1 | $14.9M | Buy |
+868,100
| New | +$14.9M | 2.21% | 17 |
|
2017
Q2 | – | Sell |
-155,265
| Closed | -$5.61M | – | 43 |
|
2017
Q1 | $5.61M | Buy |
+155,265
| New | +$5.61M | 1.11% | 22 |
|
2016
Q2 | – | Sell |
-575,000
| Closed | -$23.4M | – | 44 |
|
2016
Q1 | $23.4M | Buy |
575,000
+5,342
| +0.9% | +$217K | 8.38% | 2 |
|
2015
Q4 | $23.6M | Sell |
569,658
-657,127
| -54% | -$27.3M | 9.92% | 2 |
|
2015
Q3 | $18.9M | Buy |
1,226,785
+548,190
| +81% | +$8.44M | 7.47% | 2 |
|
2015
Q2 | $16.9M | Buy |
+678,595
| New | +$16.9M | 6.57% | 4 |
|